{{Rsnum
|rsid=1560661
|Chromosome=5
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=CD74
|position=150413894
|Gene_s=CD74
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 50.4 | 31.0
| HCB | 20.3 | 48.1 | 31.6
| JPT | 16.8 | 52.2 | 31.0
| YRI | 8.9 | 32.2 | 58.9
| ASW | 7.0 | 42.1 | 50.9
| CHB | 20.3 | 48.1 | 31.6
| CHD | 16.5 | 50.5 | 33.0
| GIH | 7.9 | 44.6 | 47.5
| LWK | 3.6 | 30.9 | 65.5
| MEX | 22.8 | 59.6 | 17.5
| MKK | 5.1 | 44.9 | 50.0
| TSI | 19.6 | 48.0 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=24220096
|Title=Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}